EC approves expanded indication for Merck’s Pneumococcal 15-valent Conjugate Vaccine
The approval facilitates availability of Vaxneuvance for this population in all 27 European Union (EU) member states plus Iceland,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pneumococcal 15-valent Conjugate Vaccine
Merck gets US FDA nod of adult pneumococcal 15-valent conjugate vaccine
VAXNEUVANCE demonstrated non-inferior immune responses for the serotypes shared with PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,…